This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Amy L. Aiello, MD; Alfredo A. Sadun, MD, PhD; Steven Feldon, MD
Los Angeles, Calif

Arch Ophthalmol. 1993;111(3):300-301.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Kwitko argues in favor of routine optic nerve sheath fenestration for treatment of progressive AION. He bases his argument on hypothetical considerations put forward by Sergott et al.¹ There is general agreement that the pathogenesis of both the progressive and nonprogressive forms of AION relate to vascular compromise, mechanical compression, or both, at the level of the lamina cribrosa within the scleral canal.² Thus, it is not clear that relieving "pressure" on the retrolaminar optic nerve would be any more beneficial than lowering the prelaminar pressure with ocular hypotensive agents. We must accept that the use of optic nerve sheath fenestration for progressive AION is supported only by a few clinical reports and not by any rigorously supported scientific hypotheses.

Kwitko suggests that the visual fields of the two patients presented in our letter³ might have been even less constricted had surgery been performed. However, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?